IGKV6-21 (Gene)

Synonyms:A26, IGKV621, NA
Id:ENSG00000282210
Description:immunoglobulin kappa variable 6-21 (non-functional) [Source:HGNC Symbol;Acc:HGNC:5836]
Predicted to be involved in immune response. Predicted to be located in plasma membrane. Predicted to be part of immunoglobulin complex. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View IGKV6-21's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with IGKV6-21.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using IGKV6-21.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for IGKV6-21.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with IGKV6-21.

Results found

Linked to

 

Label

Description

 

Phenotype

An elevated lipid concentration in the blood.

Phenotype

Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural...

Phenotype

A decreased concentration of glucose in the blood.

  • Phenotype

    An elevated lipid concentration in the blood.


  • Phenotype

    Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural...


  • Phenotype

    A decreased concentration of glucose in the blood.

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.